Dihydralazine: Difference between revisions
Matt Pijoan (talk | contribs) m (Protected "Dihydralazine": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))) |
No edit summary |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{ | {{Drugbox | ||
| IUPAC_name = | | Verifiedfields = changed | ||
| image = Dihydralazine | | Watchedfields = changed | ||
| verifiedrevid = 460786592 | |||
| IUPAC_name = 4-hydrazinyl-1-hydrazinylidene-1,2-dihydrophthalazine | |||
| image = Dihydralazine.png | |||
| image2 = Dihydralazine_ball-and-stick.png | |||
<!--Clinical data--> | |||
| tradename = | |||
| Drugs.com = {{drugs.com|international|dihydralazine}} | |||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> | |||
| pregnancy_US = <!-- A / B / C / D / X --> | |||
| pregnancy_category = | |||
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S8 --> | |||
| legal_UK = <!-- GSL / P / POM / CD --> | |||
| legal_US = <!-- OTC / Rx-only --> | |||
| legal_status = | |||
| routes_of_administration = | |||
<!--Pharmacokinetic data--> | |||
| bioavailability = | |||
| protein_bound = | |||
| metabolism = | |||
| elimination_half-life = | |||
| excretion = | |||
<!--Identifiers--> | |||
| CAS_number_Ref = {{cascite|changed|??}} | |||
| CAS_number = 484-23-1 | | CAS_number = 484-23-1 | ||
| ATC_prefix = C02 | | ATC_prefix = C02 | ||
| ATC_suffix = DB01 | | ATC_suffix = DB01 | ||
| PubChem = 10230 | | PubChem = 10230 | ||
| DrugBank = | | DrugBank_Ref = {{drugbankcite|correct|drugbank}} | ||
| | | DrugBank = | ||
| | | ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} | ||
| | | ChemSpiderID = 9813 | ||
| | | UNII_Ref = {{fdacite|correct|FDA}} | ||
| | | UNII = PCU411F5L6 | ||
| | | KEGG_Ref = {{keggcite|correct|kegg}} | ||
| | | KEGG = D07170 | ||
| | | ChEMBL_Ref = {{ebicite|correct|EBI}} | ||
| | | ChEMBL = 35505 | ||
| | |||
| | <!--Chemical data--> | ||
| C=8 | H=10 | N=6 | |||
| molecular_weight = 190.205 g/mol | |||
| | | smiles = n2nc(c1ccccc1c2NN)NN | ||
| | | InChI = 1/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14) | ||
| InChIKey = VQKLRVZQQYVIJW-UHFFFAOYAA | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChI = 1S/C8H10N6/c9-11-7-5-3-1-2-4-6(5)8(12-10)14-13-7/h1-4H,9-10H2,(H,11,13)(H,12,14) | |||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} | |||
| StdInChIKey = VQKLRVZQQYVIJW-UHFFFAOYSA-N | |||
}} | }} | ||
__NOTOC__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Dihydralazine''' is a [[ | '''Dihydralazine''' is a drug with [[antihypertensive]] properties.<ref>{{cite pmid|6477782}}</ref> It belongs to the [[hydrazinophthalazine]] [[chemical class]].<ref name=Bourreli1988>{{cite pmid|3383316}}</ref> It has very similar effects to [[hydralazine]].<ref name=Bourreli1988/> | ||
==See also== | |||
*[[Hydralazine]] | |||
==References== | |||
{{Reflist|2}} | |||
[[Category:Hydrazines]] | [[Category:Hydrazines]] | ||
[[Category:Drug]] | |||
[[ | [[Category:Antihypertensive agents]] |
Latest revision as of 14:17, 10 April 2015
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C8H10N6 |
Molar mass | 190.205 g/mol |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
WikiDoc Resources for Dihydralazine |
Articles |
---|
Most recent articles on Dihydralazine Most cited articles on Dihydralazine |
Media |
Powerpoint slides on Dihydralazine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Dihydralazine at Clinical Trials.gov Trial results on Dihydralazine Clinical Trials on Dihydralazine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Dihydralazine NICE Guidance on Dihydralazine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Dihydralazine Discussion groups on Dihydralazine Patient Handouts on Dihydralazine Directions to Hospitals Treating Dihydralazine Risk calculators and risk factors for Dihydralazine
|
Healthcare Provider Resources |
Causes & Risk Factors for Dihydralazine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Dihydralazine is a drug with antihypertensive properties.[1] It belongs to the hydrazinophthalazine chemical class.[2] It has very similar effects to hydralazine.[2]
See also
References
- ↑ PMID 6477782 (PMID 6477782)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand - ↑ 2.0 2.1 PMID 3383316 (PMID 3383316)
Citation will be completed automatically in a few minutes. Jump the queue or expand by hand
- Pages with script errors
- Pages with incomplete PMID references
- Template:drugs.com link with non-standard subpage
- Articles with changed CASNo identifier
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Chemical articles with unknown parameter in Infobox drug
- Chemical pages without DrugBank identifier
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugboxes which contain changes to watched fields
- Hydrazines
- Drug
- Antihypertensive agents